secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longevity Health Holdings, Inc. (XAGE)
CIK:        0001842939
Form:       8-K
Filed at:   2023-07-06T23:59:59+00:00
Accession:  0001193125-23-182843
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alpha Healthcare provides Carmell merger update; LOI for commercial stage allograft company with $50M revenue
--------------------------------------------------------------------------------

- Shareholder vote for Carmell merger scheduled July 11, 2023; redemption deadline July 7.
- Non-binding LOI to acquire a commercial stage allograft company with ~$50M TTM revenue and ~$5M EBITDA.
- Deal terms: $65M initial equity ($8M cash + $57M stock) plus up to $75M milestone payments (12% cash, 88% stock); 12-month lockup.
- Carmell's pipeline: Phase 2 tibia fracture trial (Fast Track), FDA agreed HEAL II start; foot/ankle fusion program.
- Post-merger ticker CTCX; plan to build leading player in aesthetics and orthopedics through roll-ups.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842939/000119312523182843/0001193125-23-182843-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842939/000119312523182843/d492441d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-182843

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer